TJ

Tim Johnson

Partner at BroadOak Capital and CEO at Horizon Infusions

Nashville, Tennessee

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Healthcare
Investment Banking
Private Equity
Mergers & Acquisitions

Education

Lists including Tim

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Bioinformatics

Series B

Total Funding: $21M

Work Experience

BC
BroadOak Capital Partners

2015

  • Partner

    2015

HI
Horizon Infusions

2019

  • Chief Executive Officer

    2019

Sa
Science and Medicine Group

2018

  • Board Member

    2018

L
LabConnect

2017

  • Chairman

    2017

PI
Pathology Inc

2009 - 2017

  • Board Member

    2009 - 2017

D
DrugScan

2008 - 2017

  • Board Observer

    2008 - 2017

MW
Mt. Weather Capital

2009 - 2017

  • General Partner

    2009 - 2017

E&
England & Company

2004 - 2015

  • Managing Director

    2004 - 2015

AA
Arthur Andersen & Co.

1993 - 1996

  • Audit Senior

    1993 - 1996